171 related articles for article (PubMed ID: 9471059)
1. Chronic lymphocytic leukemia treatment.
Dighiero G
Hematol Cell Ther; 1997 Nov; 39 Suppl 1():S31-40. PubMed ID: 9471059
[TBL] [Abstract][Full Text] [Related]
2. A systematic overview of chemotherapy effects in B-cell chronic lymphocytic leukaemia.
Kimby E; Brandt L; Nygren P; Glimelius B;
Acta Oncol; 2001; 40(2-3):224-30. PubMed ID: 11441934
[TBL] [Abstract][Full Text] [Related]
3. Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia.
Dighiero G; Maloum K; Desablens B; Cazin B; Navarro M; Leblay R; Leporrier M; Jaubert J; Lepeu G; Dreyfus B; Binet JL; Travade P
N Engl J Med; 1998 May; 338(21):1506-14. PubMed ID: 9593789
[TBL] [Abstract][Full Text] [Related]
4. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
Waselenko JK; Grever MR; Beer M; Lucas MA; Byrd JC
Semin Oncol; 2000 Apr; 27(2 Suppl 5):44-51. PubMed ID: 10877052
[TBL] [Abstract][Full Text] [Related]
5. The role of nucleoside analogues in the treatment of chronic lymphocytic leukemia-lessons learned from prospective randomized trials.
Robak T
Leuk Lymphoma; 2002 Mar; 43(3):537-48. PubMed ID: 12002757
[TBL] [Abstract][Full Text] [Related]
6. Fludarabine versus chlorambucil: is the debate over?
Rai KR; Hollweg A
Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S7-9. PubMed ID: 22035752
[TBL] [Abstract][Full Text] [Related]
7. Alkylating agents and nucleoside analogues in the treatment of B cell chronic lymphocytic leukemia.
Robak T; Kasznicki M
Leukemia; 2002 Jun; 16(6):1015-27. PubMed ID: 12040433
[TBL] [Abstract][Full Text] [Related]
8. Therapy of chronic lymphocytic leukemia with purine analogs and monoclonal antibodies.
Robak T
Transfus Apher Sci; 2005 Feb; 32(1):33-44. PubMed ID: 15737872
[TBL] [Abstract][Full Text] [Related]
9. Bendamustine for the treatment of chronic lymphocytic leukemia and rituximab-refractory, indolent B-cell non-Hodgkin lymphoma.
Dennie TW; Kolesar JM
Clin Ther; 2009; 31 Pt 2():2290-311. PubMed ID: 20110042
[TBL] [Abstract][Full Text] [Related]
10. Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL.
Johnson S; Smith AG; Löffler H; Osby E; Juliusson G; Emmerich B; Wyld PJ; Hiddemann W
Lancet; 1996 May; 347(9013):1432-8. PubMed ID: 8676625
[TBL] [Abstract][Full Text] [Related]
11. Treatment of chronic lymphocytic leukaemia. French Co-operative Group on CLL.
Binet JL
Baillieres Clin Haematol; 1993 Dec; 6(4):867-78. PubMed ID: 8038494
[TBL] [Abstract][Full Text] [Related]
12. The place of cladribine in the treatment of chronic lymphocytic leukemia: a 10-year experience in Poland.
Robak T
Ann Hematol; 2005 Feb; 84(2):63-70. PubMed ID: 15558283
[TBL] [Abstract][Full Text] [Related]
13. Management of chronic lymphocytic leukaemia.
Kalil N; Cheson BD
Drugs Aging; 2000 Jan; 16(1):9-27. PubMed ID: 10733261
[TBL] [Abstract][Full Text] [Related]
14. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
Robak T; Lech-Maranda E; Robak P
Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
[TBL] [Abstract][Full Text] [Related]
15. Purine antagonists for chronic lymphocytic leukaemia.
Steurer M; Pall G; Richards S; Schwarzer G; Bohlius J; Greil R
Cochrane Database Syst Rev; 2006 Jul; 2006(3):CD004270. PubMed ID: 16856041
[TBL] [Abstract][Full Text] [Related]
16. Chlorambucil for the treatment of patients with chronic lymphocytic leukemia (CLL) - a systematic review and meta-analysis of randomized trials.
Vidal L; Gurion R; Ram R; Raanani P; Bairey O; Robak T; Gafter-Gvili A; Shpilberg O
Leuk Lymphoma; 2016 Sep; 57(9):2047-57. PubMed ID: 26980554
[TBL] [Abstract][Full Text] [Related]
17. New agents in chronic lymphocytic leukemia.
Robak T
Curr Treat Options Oncol; 2006 May; 7(3):200-12. PubMed ID: 16615876
[TBL] [Abstract][Full Text] [Related]
18. Does intensive treatment with high dose chlorambucil and prednisone as first line and cladribine as second line influence the survival of the patients with chronic lymphocytic leukemia?
Robak T; Błoński JZ; Kasznicki M
Leuk Lymphoma; 2001 May; 41(5-6):545-57. PubMed ID: 11378572
[TBL] [Abstract][Full Text] [Related]
19. Chlorambucil plus theophylline vs chlorambucil alone as a front line therapy for B-cell chronic lymphatic leukemia.
Mabed M; Aref S; Fouda M; El-Sharawy S
Leuk Lymphoma; 2004 Oct; 45(10):2029-35. PubMed ID: 15370247
[TBL] [Abstract][Full Text] [Related]
20. Therapy of chronic lymphocytic leukaemia with purine nucleoside analogues: facts and controversies.
Robak T
Drugs Aging; 2005; 22(12):983-1012. PubMed ID: 16363884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]